Revenue
1.32 million USD
2010-09-30 · USD
Exact inputs and evidence
- Revenue: 1320000 USD Source
Fundies. English
Laxai Pharma Ltd
EDGAR13 filing records in this dataset, filed from 2007-12-31 to 2010-11-19. Explore the available filing history and original sources.
Latest quarter
Net margin
-22.2%
2010-09-30 · %
Operating cash flow
-76 thousand USD
2010-09-30 · USD
- Cash and cash equivalents
- 60 thousand USD Source
Exact value
60000 USD
- Long-term debt including current maturities
- Not available
- Shares outstanding
- Not available
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2010-11-19.
Financial data available through: 2009-12-31.
Coverage by financial measure
- revenue: No compatible figures in this window
- operating income: No compatible figures in this window
- Net income: 9 of 11 periods available· newest 2009-12-31
- Operating cash flow: 9 of 11 periods available· newest 2009-12-31
- capital expenditure: No compatible figures in this window
- Total assets: 6 of 11 periods available· newest 2009-12-31
- liabilities: No compatible figures in this window
- Current assets: 6 of 11 periods available· newest 2009-12-31
- Current liabilities: 6 of 11 periods available· newest 2009-12-31
- Cash and cash equivalents: 9 of 11 periods available· newest 2009-12-31
- long term debt: No compatible figures in this window
- shares outstanding: No compatible figures in this window
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Net income
+USD 1.53 millionPrior period
−USD 1.93 million
–
Current period
−USD 404,000
–
Exact inputs and evidence
-404000 − -1929000 = 1525000 USD
-1929000 USD · 2008-01-01 – 2008-12-31
Inspect prior input Prior source-404000 USD · 2009-01-01 – 2009-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 995,000Prior period
−USD 1.35 million
–
Current period
−USD 350,000
–
Exact inputs and evidence
-350000 − -1345000 = 995000 USD
-1345000 USD · 2008-01-01 – 2008-12-31
Inspect prior input Prior source-350000 USD · 2009-01-01 – 2009-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue, Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
Revenue is not reported for this company, so its costs cannot be shown as a share of it.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Revenue growth
Change in revenue from the same financial period one year earlier.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Not enough comparable data to show this history.
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|
Operating cash flow
Cash generated by the company’s normal business operations.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Current assets to current liabilities
Current assets divided by current liabilities.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2006 2006-01-01 – 2006-12-31 | −USD 496,000 Exact valueExact value: -496000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 151,000 Exact valueExact value: -151000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2007 2006-04-01 – 2007-03-31 | −USD 1.63 million Exact valueExact value: -1629000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 845,000 Exact valueExact value: -845000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2007 2006-07-01 – 2007-06-30 | −USD 1.03 million Exact valueExact value: -1030000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.07 million Exact valueExact value: -1071000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2007 2006-10-01 – 2007-09-30 | −USD 1.48 million Exact valueExact value: -1480000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.28 million Exact valueExact value: -1284000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2007 2007-01-01 – 2007-12-31 | −USD 1.63 million Exact valueExact value: -1629000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 845,000 Exact valueExact value: -845000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2008 2007-07-01 – 2008-06-30 | −USD 1.4 million Exact valueExact value: -1399000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.05 million Exact valueExact value: -1047000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2008 2007-10-01 – 2008-09-30 | −USD 1.69 million Exact valueExact value: -1691000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.24 million Exact valueExact value: -1240000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2008 2008-01-01 – 2008-12-31 | −USD 1.93 million Exact valueExact value: -1929000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.35 million Exact valueExact value: -1345000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2009 2009-01-01 – 2009-12-31 | −USD 404,000 Exact valueExact value: -404000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 350,000 Exact valueExact value: -350000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
13 filings · 0 latest values · 0 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0000835688, 835688, edgar:835688
Also known as HEALTHCARE TECHNOLOGIES LTD, NEXGEN BIOFUELS LTD